Apr 27, 2017 11:03 am UTC| Business
Key updates With the clearance of the investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA), ProQR can now start clinical development of QR-110 in Leber’s congenital amaurosis Type 10...
Apr 27, 2017 11:03 am UTC| Business
Key updates With the clearance of the investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA), ProQR can now start clinical development of QR-110 in Leber’s congenital amaurosis Type 10...
Apr 27, 2017 11:02 am UTC| Business
Key updates With the clearance of the investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA), ProQR can now start clinical development of QR-110 in Leber’s congenital amaurosis Type 10...
MacroGenics Announces Registered Direct Offering of Common Stock
Apr 27, 2017 11:02 am UTC| Business
Rockville, MD, April 27, 2017 -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
MacroGenics Announces Registered Direct Offering of Common Stock
Apr 27, 2017 11:02 am UTC| Business
Rockville, MD, April 27, 2017 -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
MacroGenics Announces Registered Direct Offering of Common Stock
Apr 27, 2017 11:02 am UTC| Business
Rockville, MD, April 27, 2017 -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
Midstates Petroleum Schedules First Quarter 2017 Earnings Release and Conference Call
Apr 27, 2017 11:02 am UTC| Business
TULSA, Okla., April 27, 2017 -- Midstates Petroleum Company, Inc.(NYSE MKT:MPO) (“Midstates” or the “Company”)today announced that its first quarter 2017 earnings release will be issued on Monday, May 8, after the close...